-
Targeted sequencing about core genes involved in telomere biology in colorectal cancer patients
Study
EGAS00001002977
-
Identification of the mutational consequences of precancerous liver disease (including alcohol abuse) on the genomes of human adult stem cells.
Study
EGAS00001002983
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Role_of_HPV_and_Interferon_in_APOBEC_mutational_signature
Study
EGAS00001002988
-
A benchmarking resource for NGS testing of cancer predisposition genes
Study
EGAS00001002993
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Epigenetic profiling of colorectal cancer initiating cells (CC-ICs) to identify bivalently marked genes (H3K4me3 and H3K27me3 ChIP-seq), and investigation of changes in transcriptome following EZH2 inhibition using RNA-seq.
Study
EGAS00001003003
-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Mapping the breast cancer metastatic cascade onto circulating tumour DNA using genetic and epigenetic clonal tracking
Study
EGAS00001004014
-
Effect_of_FAM50_knockout_on_the_transcriptome
Study
EGAS00001004836
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___BD___WGS
Study
EGAS00001003014
-
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Study
EGAS00001004888
-
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Study
EGAS00001004030
-
RNA-seq data from Non Small Cell Lung Cancer (NSCLC) samples
Study
EGAS00001004032
-
Tumor HTG EdgeSeq from metastatic castrate resistant prostate cancer
Study
EGAS00001004852
-
Heterogeneous metabolic signatures are linked to cancer cell differentiation in colorectal cancer
Study
EGAS00001004064
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Somatic_mutation_and_clonal_evolution_in_the_human_testes___WES
Study
EGAS00001003023
-
Oesophageal_Adenocarcinoma_Organoids_Iso_Seq
Study
EGAS00001004051
-
Whole_Genome_Sequencing_of_Human_Organoid_Lines
Study
EGAS00001003538
-
Genomic and transcriptomic landscape of aggressive thyroid cancer
Study
EGAS00001003540
-
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary with Neuroendocrine Differentiation
Study
EGAS00001003026
-
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Study
EGAS00001005549
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Whole exome sequencing on Pediatric MDS patients
Study
EGAS00001005432